Article
![Sepsis Sepsis](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/JFP07201e13_1100x725.jpg)
Consider this tool to reduce antibiotic-associated adverse events in patients with sepsis
- Author:
- Timothy Mott, MD, FAAFP
- Zachary Orme, DO
Predictive biomarker procalcitonin can aid clinical decision-making on continued antibiotic treatment in this patient population.